A systemic view on the distribution of diet-derived methanol and hepatic acetone in mice

Volatile organic compounds (VOCs) from breath can successfully be used to diagnose disease-specific pathological alterations in metabolism. However, the exact origin and underlying biochemical pathways that could be mapped to VOC signatures are mainly unknown. There is a knowledge gap regarding the contribution of tissues, organs, the gut microbiome, and exogenous factors to the ‘sum signal’ from breath samples. Animal models for human disease such as mutant mice provide the possibility to reproduce genetic predisposition to disease, thereby allowing in-depth analysis of metabolic and biochemical functions. We hypothesized that breath VOCs can be traced back to origins and organ-specific metabolic functions by combining breath concentrations with systemic levels detected in different organs and biological media (breath, blood, feces and urine). For this we fed C57Bl/6N mice a grain-based chow or a purified low-fat diet, thereby modifying the emission of methanol in breath whereas acetone levels were unaffected. We then measured headspace concentrations of both VOCs in ex vivo samples of several biological media. Cecum content especially was identified as a likely source of systemic methanol, whereas the liver showed highest acetone concentrations. Our findings are a first step to the systemic mapping of VOC patterns to metabolic functions in mice because differences between VOCs could be traced to different sources in the body. As a future aim, different levels of so-called omics technologies (genomics, proteomics, metabolomics, and breathomics) could be mapped to metabolic pathways in multiple tissues, deepening our understanding of VOC metabolism and possibly leading to early non-invasive biomarkers for human pathologies.

[1]  D. Fischer,et al.  Exhaled volatile substances mirror clinical conditions in pediatric chronic kidney disease , 2017, PloS one.

[2]  F. Biasioli,et al.  Genome-wide association study unravels the genetic control of the apple volatilome and its interplay with fruit texture , 2017, Journal of experimental botany.

[3]  R. Zenobi,et al.  Gauging circadian variation in ketamine metabolism by real-time breath analysis. , 2017, Chemical communications.

[4]  P. Puchalska,et al.  Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. , 2017, Cell metabolism.

[5]  H. Haick,et al.  Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules , 2016, ACS nano.

[6]  Heather D. Bean,et al.  Comparative analysis of the volatile metabolomes of Pseudomonas aeruginosa clinical isolates , 2016, Journal of breath research.

[7]  C. Wijmenga,et al.  Volatile organic compounds in breath as markers for irritable bowel syndrome: a metabolomic approach , 2016, Alimentary pharmacology & therapeutics.

[8]  D. Sessler,et al.  Exhalation of volatile organic compounds during hemorrhagic shock and reperfusion in rats: an exploratory trial , 2016, Journal of breath research.

[9]  K. Unterkofler,et al.  A Compendium of Volatile Organic Compounds (VOCs) Released By Human Cell Lines , 2016, Current medicinal chemistry.

[10]  H. Fuchs,et al.  Diet-induced and mono-genetic obesity alter volatile organic compound signature in mice , 2016, Journal of breath research.

[11]  David Smith,et al.  Increase of methanol in exhaled breath quantified by SIFT-MS following aspartame ingestion , 2015, Journal of breath research.

[12]  Q. Jöbsis,et al.  Can exhaled volatile organic compounds predict asthma exacerbations in children? , 2015, Journal of breath research.

[13]  T. Whitehouse,et al.  Volatile Biomarkers in Breath Associated With Liver Cirrhosis — Comparisons of Pre- and Post-liver Transplant Breath Samples , 2015, EBioMedicine.

[14]  Y. Dorokhov,et al.  Metabolic methanol: molecular pathways and physiological roles. , 2015, Physiological reviews.

[15]  C. Seger,et al.  Non-13CO2 targeted breath tests: a feasibility study , 2014, Journal of breath research.

[16]  Bettina Zelger,et al.  Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers , 2014, Journal of breath research.

[17]  H. Schulz,et al.  Online breath gas analysis in unrestrained mice by hs-PTR-MS , 2014, Mammalian Genome.

[18]  C Hoeschen,et al.  Effects of diet-matrix on volatile organic compounds in breath in diet-induced obese mice , 2014, Journal of breath research.

[19]  Joachim D Pleil,et al.  Clinical breath analysis: discriminating between human endogenous compounds and exogenous (environmental) chemical confounders , 2013, Journal of breath research.

[20]  Franco Biasioli,et al.  Analysis of breath by proton transfer reaction time of flight mass spectrometry in rats with steatohepatitis induced by high-fat diet. , 2012, Journal of mass spectrometry : JMS.

[21]  Stef van Buuren,et al.  MICE: Multivariate Imputation by Chained Equations in R , 2011 .

[22]  P. G. Wells,et al.  Species differences in methanol and formic acid pharmacokinetics in mice, rabbits and primates. , 2010, Toxicology and applied pharmacology.

[23]  C. Hoeschen,et al.  Discrimination of cancerous and non-cancerous cell lines by headspace-analysis with PTR-MS , 2010, Analytical and bioanalytical chemistry.

[24]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[25]  T. Clutton-Brock,et al.  Endogenous volatile organic compounds in breath and blood of healthy volunteers: examining breath analysis as a surrogate for blood measurements , 2009, Journal of breath research.

[26]  H. Fuchs,et al.  The German Mouse Clinic: a platform for systemic phenotype analysis of mouse models. , 2009, Current pharmaceutical biotechnology.

[27]  E. Skrzydlewska Toxicological and Metabolic Consequences of Methanol Poisoning , 2003, Toxicology mechanisms and methods.

[28]  J. Gordon,et al.  Commensal Host-Bacterial Relationships in the Gut , 2001, Science.

[29]  K. Ward,et al.  Development of a physiologically based pharmacokinetic model to describe the disposition of methanol in pregnant rats and mice. , 1997, Toxicology and applied pharmacology.

[30]  A. Hansel,et al.  Endogenous production of methanol after the consumption of fruit. , 1997, Alcoholism, clinical and experimental research.

[31]  M. Higuchi,et al.  Physiologically based pharmacokinetic model for methanol in rats, monkeys, and humans. , 1992, Toxicology and applied pharmacology.

[32]  D Mackay,et al.  Correlation of tissue, blood, and air partition coefficients of volatile organic chemicals. , 1989, British journal of industrial medicine.

[33]  A. Andersen,et al.  Cancer incidence among workers exposed to radon and thoron daughters at a niobium mine. , 1985, Scandinavian journal of work, environment & health.

[34]  J. Axelrod,et al.  REGIONAL AND SUBCELLULAR DISTRIBUTION OF PROTEIN CARBOXYMETHYLASE IN BRAIN AND OTHER TISSUES , 1976, Journal of neurochemistry.

[35]  J. Axelrod,et al.  Characterization and substrate specificity of a protein carboxymethylase in the pituitary gland. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Axelrod,et al.  Pituitary Gland: Enzymic Formation of Methanol from S-Adenosylmethionine , 1965, Science.

[37]  A. B. Kulkarni,et al.  Methanol in Normal Human Breath , 1963, Science.

[38]  Physiologically-based pharmacokinetic model) , 2016 .

[39]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[40]  T. Stanley Species differences. , 1988, British journal of anaesthesia.

[41]  Vera Fiserova-Bergerova,et al.  Determination and prediction of tissue-gas partition coefficients , 1986, International archives of occupational and environmental health.

[42]  V. Fiserova-Bergerova Toxicokinetics of organic solvents. , 1985, Scandinavian journal of work, environment & health.